Extracellular matrix induces trophoblast HtrA4 expression: Implications for the pathogenesis of placenta accreta spectrum
Placenta · 2025
DOI: 10.1016/j.placenta.2025.04.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2025. Verfasst von Chie-Pein Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of High Risk Pregnancy, MacKay Memorial Hospital, Taipei, Taiwan; Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan. …. Hauptthemen laut MEDLINE: Trophoblasts, Extracellular Matrix, Placenta Accreta, Serine Proteases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: MacKay Memorial Hospital.
Abstract (Originalsprache)
OBJECTIVE: To study whether the upregulation of HtrA4 expression in extravillous trophoblasts and the downregulation of HtrA1 expression in defective deciduae underlined the mechanisms of placenta accreta spectrum (PAS) development. METHODS: Tissue samples from patients undergone cesarean hysterectomy because of postpartum hemorrhage due to PAS (n = 15) or uterine atony (control group; n = 10) were analyzed through immunostainings. The effect of extracellular matrix (ECM) on trophoblast HtrA4 expression, and HtrA4 in the alteration of trophoblast epithelial-to-mesenchymal transition, proliferation, invasion and HtrA1 inhibition were assessed. RESULTS: ECM molecule collagen I, collagen IV, fibronectin, or laminin were highly expressed in decidua and myometrium. Culturing trophoblasts with these molecules induced HtrA4 expression. HtrA4 upregulated the expression of N-cadherin, vimentin, integrin β1, snail, and matrix metalloproteinase-2 but downregulated that of zonula occludens-1. HtrA4 knockdown inhibited these effects. HtrA4 knockdown or pretreatment with recombinant HtrA1 inhibited HtrA4-induced trophoblast invasion. HtrA4 promoted trophoblast proliferation. Numerous extravillous trophoblasts exhibiting strong HtrA4 expression invaded the myometrium at the villous adherence sites affected by PAS. Relatively few extravillous trophoblasts were observed at the nonadherence sites and in the control specimens; these trophoblasts exhibited weak or no HtrA4 expression. HtrA1 was primarily expressed over the decidua. DISCUSSION: ECM in decidua and myometrium induced trophoblast HtrA4 expression. Decidual HtrA1 inhibited HtrA4-induced trophoblast invasion. Without the inhibition of HtrA1, HtrA4 expression and invasion was upregulated in the trophoblasts of patients with PAS. The reciprocal effects of HtrA4 and HtrA1 at the maternal-fetal interface may be involved in the pathogenesis of PAS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of High Risk Pregnancy, MacKay Memorial Hospital, Taipei, Taiwan; Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan. Electronic address: cpchen@mmh.org.tw.
- Division of High Risk Pregnancy, MacKay Memorial Hospital, Taipei, Taiwan; Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan.
- Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan.
- Institute of Biological Chemistry, Academia Sinica, Nankang, Taipei, Taiwan.
Förderung
- MacKay Memorial Hospital
Zitieren
APA
Chen, C. P., Chen, C. Y., Chen, C. Y., Kuo, Y. H., & Chen, H. (2025). Extracellular matrix induces trophoblast HtrA4 expression: Implications for the pathogenesis of placenta accreta spectrum. Placenta. https://doi.org/10.1016/j.placenta.2025.04.028
Vancouver
Chen CP, Chen CY, Chen CY, Kuo YH, Chen H. Extracellular matrix induces trophoblast HtrA4 expression: Implications for the pathogenesis of placenta accreta spectrum. Placenta. 2025. doi:10.1016/j.placenta.2025.04.028
BibTeX
@article{Chen2025,
author = {Chen, Chie-Pein and Chen, Chen-Yu and Chen, Chia-Yu and Kuo, Yi-Hsiu and Chen, Hungwen},
title = {Extracellular matrix induces trophoblast HtrA4 expression: Implications for the pathogenesis of placenta accreta spectrum},
journal = {Placenta},
year = {2025},
doi = {10.1016/j.placenta.2025.04.028}
}
EUVIMED